Anda, a long-standing distributor in the pharmaceutical industry, has secured $1.2 million in new funding. Since 1992, Anda has been dedicated to assisting customers in the pharmaceutical sector and physician practices by providing on-time access to quality products and customer-centric services. The company serves as a distributor for nearly 400 manufacturers, offering a comprehensive product line of over 15,000 items across various therapeutic categories.
Anda's portfolio is designed to complement primary wholesaler programs, support patient needs, and facilitate revenue growth initiatives such as pet medications, immunization services, diabetes care, point-of-care testing, and smoking cessation programs. Its product offerings include generic, brand, and specialty pharmaceuticals, injectables, vaccines/biologicals, diagnostic tests, medical and surgical supplies, OTC products, vitamins, nutritional supplements, and both prescription and over-the-counter pet medications. The company's professional account representatives work with a diverse customer base, including retail independent and chain pharmacies, physician offices, nursing homes, hospitals, and clinics.
This capital infusion will support Anda's ongoing operations and strategic growth initiatives. The company plans to leverage the investment to further enhance its service capabilities, expand its product offerings, and strengthen its market position. Anda currently fulfills orders through multiple channels, including online, phone, Electronic Data Interchange (EDI), and fax, offering flexible ordering options, extended cut-off times, and next-day delivery to ensure enhanced product access for its customers. The funding is expected to bolster Anda's capacity to continue meeting the evolving demands of the healthcare supply chain and support its long-term expansion plans.
